Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor

A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding. The patient was later diagnosed with severe thrombocytopenia and a stage G1, well-differentiated gastric neuroendocrine tumor, confirmed by a biopsy. A total gastrectomy was performed to eradicate the tumor. After being treated with a total splenectomy for her Evans Syndrome with no clinical or laboratory improvement, she began regular treatment with octreotide on the basis of a possible hepatic metastasis. Days after the initiation of the octreotide, an increase in the platelet count was evidenced by laboratory findings, from 2,000 platelets/mm3 to 109,000 platelets/mm3 . Weeks later, the hepatic metastasis is discarded by a negative octreotide-body scan, and the octreotide treatment was interrupted. Immediately after the drug interruption, a progressive and evident descent in the platelet count was evidenced (4000 platelets/mm3 ). The present case report highlights the possible association between octreotide treatment and a severe thrombocytopenia resistant to conventional treatment.
Authors: Chung Delgado, KocfaRevilla Montag, AlejandroGuillén Bravo, SoniaRíos Díaz, HugoAlva Muñoz, José C.
Source: Case Reports in Hematology 

URL: http://hdl.handle.net/10757/314004

Comentarios

Entradas populares de este blog

Exportación de muebles de madera hacia el mercado de los Estados Unidos de Norteamérica

Propuesta para el incremento de consumo de café tostado de los asociados de la Junta Nacional del Café

Propuesta de una arquitectura empresarial para el proceso gestión de operaciones de la Compañía de Seguros de Vida Cámara